98697887 - SHAREVAC

Information

  • Trademark
  • 98697887
  • Serial Number
    98697887
  • Filing Date
    August 14, 2024
    a year ago
  • Transaction Date
    July 15, 2025
    4 months ago
  • Status Date
    July 14, 2025
    4 months ago
  • Location Date
    June 03, 2025
    5 months ago
  • Status Code
    680
  • Current Location
    TMO LAW OFFICE 127
    Employee Name
    SCHRADER, BRITTANY
  • Attorney Docket Number
    067249-00064
    Attorney Name
    Jennifer Fraser
    Law Office Assigned Location Code
    N90
  • Owners
Mark Drawing Code
4
Mark Identification
SHAREVAC
Case File Statements
  • GS0091: Scientific and laboratory apparatus for chemical synthesis; laboratory equipment, namely, mobile laboratory equipped with scientific or laboratory apparatus for chemical synthesis; laboratory equipment, namely, mobile laboratory equipped with scientific or laboratory apparatus for purification and analysis of synthesized compounds; laboratory equipment, namely, mobile device for the synthesis of macromolecules; Scientific and laboratory apparatus for chemical or biological analysis and/or synthesis; laboratory equipment, namely, mobile production station of biological macromolecules for laboratory or and for cell culturing for therapeutic use; Bioreactors for laboratory or and for cell culturing for therapeutic use
  • GS0071: Bioreactors for use in manufacturing biopharmaceuticals; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industry roboters being industrial robots
  • GS0051: Chemical preparations for medical use, in particular biological macromolecules, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Pharmaceutical preparations namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; Pharmaceuticals preparations and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for the treatment of metabolic disorders and for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations being Nucleic acid macromolecules for in vivo or in vitro expression for human and veterinary use; Dietetic substances adapted for medical use, in particular substances for food supplements; Vaccines
  • PM0001: SHARE VAC
  • GS0011: Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
  • GS0441: Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for the treatment of metabolic disorders; Vaccination services in the nature of administering vaccines to patients
  • GS0421: Scientific and technological services, namely, and scientific research , in particular for identification, testing and characterisation of biological molecules; scientific research in the nature of pre-clinical and clinical testing of macromolecules for others; Custom synthesis of chemical compounds, in particular biological macromolecules
Case File Event Statements
  • 8/14/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/17/2025 - 10 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/20/2025 - 8 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/4/2025 - 8 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/4/2025 - 8 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/3/2025 - 5 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/3/2025 - 5 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/4/2025 - 8 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/3/2025 - 5 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/14/2025 - 4 months ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA